ArticleJournal of oncology2023

Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study.

Kang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.